Illustrative image – not actual.Silico Insights Inc of USA is developing a tissue testing laboratory in Hyderabad, through its Indian subsidiary, Silico Insights Biosciences India (SIBI).
The laboratory will focus on molecular profiling, collection of data for experimentation, feeding of data through software tools and discover drugs, especially for cancer diseases.
A unique bioinformatics tool – i-Sight Discovery – developed by the parent American company would be extensively utilised by SIBI. The tool helps in extracting knowledge from complex drug data and in analyse data profile for disease pathways. The information thus derived is stored and reused during the drug development process.
The scheme, estimated to entail an investment of $2 million (approx Rs.9.24 crore), will be partially funded by APIDC Venture Capital (APIDC-VCL).
